Minerva Neurosciences Names Dr. Justine Lalonde as Senior Vice President, Product Strategy
31 oct. 2017 08h00 HE
|
Minerva Neurosciences, Inc
WALTHAM, Mass., Oct. 31, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central...